Announcements
- Minutes of Annual General Meeting 2024
- Disclosure of voting rights for Chair of the Board
- PCI Biotech Holding ASA - Notice of Annual General Meeting 2024
- PCI Biotech Holding ASA - Annual Report 2023
- PCI Biotech second half 2023 interim results
- PCI Biotech: Invitation to second half interim 2023 results presentation
- PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
- PCI Biotech: European patent for mRNA delivery with fimaNAc
- PCI Biotech: Employee share option scheme
- PCI Biotech: Write-down of share capital registered
More ▼
Key statistics
On Friday, PCI Biotech Holding ASA (4QG:STU) closed at 0.1586, 64.86% above the 52 week low of 0.0962 set on Oct 11, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1656 |
---|---|
High | 0.1768 |
Low | 0.1566 |
Bid | 0.155 |
Offer | 0.1922 |
Previous close | 0.1686 |
Average volume | 6.00k |
---|---|
Shares outstanding | 37.33m |
Free float | 28.39m |
P/E (TTM) | -- |
Market cap | 84.17m NOK |
EPS (TTM) | -0.5443 NOK |
Data delayed at least 15 minutes, as of Jun 07 2024.
More ▼